Yohannes, Dawit A.
Freitag, Tobias L.
de Kauwe, Andrea
Kaukinen, Katri
Kurppa, Kalle
Wacklin, Pirjo
Mäki, Markku
Arstila, T. Petteri
Anderson, Robert P.
Greco, Dario
Saavalainen, Päivi
Article History
Received: 7 July 2017
Accepted: 6 December 2017
First Online: 21 December 2017
Competing Interests
: RPA is co-inventor of patents related to therapeutics, diagnostics, food tests and non-toxic cereals for coeliac disease. RPA is also an employee and shareholder of ImmusanT Inc (a company developing therapeutics and diagnostics for coeliac disease), and is also a shareholder in Nexpep Pty. Ltd, which holds shares in ImmusanT, Inc. All other authors declare no competing interests.